Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. - Glascock A; Maguire C; Phan HV; Lydon EC; Schaenman J; Calfee CS; Melamed E; Greenland J; Corry DB; Kheradmand F; Baden LR; Sekaly R; et al. (Nature microbiology, 2026)